PharmaZell GmbH proposed to acquire Groupe Novasep SAS from BlackRock, Inc. (NYSE:BLK) and Silver Point Capital L.P. on September 16, 2021. The transaction is backed by Bridgepoint. The transaction remains subject to the fulfilment of customary conditions precedent for this type of transaction including the information and consultation of works councils and other regulatory approvals.

Rothschild & Co SCA acted as financial advisor, Marc Castagnede, Romy Richter, Guillaume Valois, Guillaume Auzanneau, Arthur Sauzay, Gabrielle Nivet, Marianne Delassaussé, Luc Lamblin, Olivier Picquerey, Hovig Cancioglu of Allen & Overy France, Nils Koffka, Roman Kasten, Hannah Wohlfarth, Udo Olgemöller, Sebastian Schulz, Jürgen Schindler, Robin Harvey, Nihaal Khanna, Matthew Appleton, Jules Lecoeur, Emma Fata, Charles-Hugo Lerebour, Eda Zhuleku, Kenneth Rivlin, Richard Qiang, Chaohui Liang, Matt Huggett, Matthew Townsend, Tim Müller and Sebastian Schulz of Allen & Overy LLP, Sarah-Jayne Mackin and Laura Campbell of Allen & Overy (SSF) Limited acted as legal advisor and Ernst & Young LLP acted as accountant to PharmaZell GmbH. Jefferies Financial Group Inc. acted as financial advisor, Cleary Gottlieb Steen & Hamilton LLP acted as legal advisor and Ernst & Young LLP acted as accountant to Groupe Novasep SAS. Rabindra Jhunjhunwala, Roshnek Dhalla of Khaitan & co advised Allen & Overy LLP as legal advisor.

PharmaZell GmbH completed the acquisition of Groupe Novasep SAS from BlackRock, Inc. (NYSE:BLK) and Silver Point Capital L.P. on April 7, 2022.